MX2016003046A - Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos. - Google Patents

Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.

Info

Publication number
MX2016003046A
MX2016003046A MX2016003046A MX2016003046A MX2016003046A MX 2016003046 A MX2016003046 A MX 2016003046A MX 2016003046 A MX2016003046 A MX 2016003046A MX 2016003046 A MX2016003046 A MX 2016003046A MX 2016003046 A MX2016003046 A MX 2016003046A
Authority
MX
Mexico
Prior art keywords
methods
making
same
microbial infection
antimicrobial compounds
Prior art date
Application number
MX2016003046A
Other languages
English (en)
Inventor
Ashoke Bhattacharjee
F Kanyo Zoltan
Original Assignee
Melinta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Therapeutics Inc filed Critical Melinta Therapeutics Inc
Publication of MX2016003046A publication Critical patent/MX2016003046A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En el presente se divulgan métodos y compuestos para tratar, prevenir, reducir el riesgo de, y/o retrasar la aparición de una infección microbiana en un sujeto, en donde la infección microbiana es causada por uno o más microorganismos (por ejemplo, una o más bacterias) que pueden utilizarse como arma biológica, tales como Bacillus anthracis, Franciscella tularensis, Yersina pestis, Burkholderia mallei, y Burkholderia pseudomallei. También se divulgan composiciones farmacéuticas o kits para tratar, prevenir, reducir el riesgo de y/o retrasar la aparición de una infección microbiana.
MX2016003046A 2013-09-09 2014-09-09 Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos. MX2016003046A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361875642P 2013-09-09 2013-09-09
PCT/US2014/054860 WO2015035421A1 (en) 2013-09-09 2014-09-09 Antimicrobial compounds and methods of making and using the same

Publications (1)

Publication Number Publication Date
MX2016003046A true MX2016003046A (es) 2016-09-08

Family

ID=52629043

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016003046A MX2016003046A (es) 2013-09-09 2014-09-09 Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.

Country Status (7)

Country Link
US (1) US9937183B2 (es)
EP (1) EP3038623A4 (es)
JP (1) JP2016529325A (es)
AU (1) AU2014315045A1 (es)
CA (1) CA2923179A1 (es)
MX (1) MX2016003046A (es)
WO (1) WO2015035421A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102725274A (zh) 2009-10-16 2012-10-10 Rib-X制药公司 抗微生物化合物和其制备和使用方法
MX359743B (es) 2009-10-16 2018-10-08 Melinta Therapeutics Inc Compuestos antimicrobianos y métodos para fabricar y utilizar los mismos.
MX2016003046A (es) 2013-09-09 2016-09-08 Melinta Therapeutics Inc Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.
KR20160070066A (ko) * 2013-09-09 2016-06-17 멜린타 테라퓨틱스, 인크. 항균 화합물, 및 이의 제조 방법 및 이용 방법
BR112017019349A2 (pt) * 2015-03-11 2018-06-05 Melinta Therapeutics Inc compostos antimicrobianos e métodos de fabricação e uso dos mesmos
WO2017193023A1 (en) * 2016-05-06 2017-11-09 Melinta Therapeutics, Inc. Antimicrobials and methods of making and using same
CN110312722A (zh) 2016-05-06 2019-10-08 生物验证系统股份公司 抗微生物剂及其制备和使用方法
US11122800B2 (en) * 2017-10-30 2021-09-21 Troy Corporation Antimicrobial organic preservatives
US20210253577A1 (en) 2018-06-06 2021-08-19 BioVersys AG Biodefense agents
WO2020115547A2 (en) * 2018-12-07 2020-06-11 BioVersys AG Pyrrolo[2,3-d]pyrimidin-2-one antimicrobial compounds
JP2023501575A (ja) * 2019-11-13 2023-01-18 カーザ グローバル， エルエルシー 抗菌化合物及び方法

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2624731A (en) 1953-01-06 S-phenylpyrimidkn e x derivativesx
US3980781A (en) 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
US4361557A (en) 1980-01-28 1982-11-30 Schering Corporation 1-Aryl-2-acylamido-3-fluoro-1-propanol acylates, methods for their use as anti-bacterial agents and compositions useful therefor
EP0067610A1 (en) 1981-06-16 1982-12-22 Beecham Group Plc Penicillins, a process for their preparation and compositions containing them
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5332835A (en) 1984-02-03 1994-07-26 Zambon S.P.A. Process for fluorinating 1-phenyl-2-amino-1,3-propanediol compounds and new oxazoline compounds useful in this process
JPS6191184A (ja) 1984-10-08 1986-05-09 Morishita Seiyaku Kk ２−アニリノ−５−（１ｈ−テトラゾ−ル−５−イル）ピリミジン−４（３ｈ）−オン誘導体
JP2873340B2 (ja) 1988-04-29 1999-03-24 武田薬品工業株式会社 抗生物質ｔａｎ―１０５７，その製造法および用途
JP2991382B2 (ja) 1990-07-18 1999-12-20 大日本製薬株式会社 縮合三環式化合物およびその塩
US5208141A (en) 1990-10-09 1993-05-04 Konica Corporation Silver halide color photographic light-sensitive material
US5958930A (en) 1991-04-08 1999-09-28 Duquesne University Of The Holy Ghost Pyrrolo pyrimidine and furo pyrimidine derivatives
US6451968B1 (en) 1991-05-24 2002-09-17 Isis Pharmaceuticals, Inc. Peptide nucleic acids
US5434257A (en) 1992-06-01 1995-07-18 Gilead Sciences, Inc. Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages
US5646163A (en) 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
RU2139862C1 (ru) 1993-05-12 1999-10-20 Е.И. Дю Пон де Немурс энд Компани Замещенные 4(3н)-хиназолиноны, обладающие фунгицидными свойствами, композиции на их основе и способы борьбы с мучнистой росой
US5502177A (en) 1993-09-17 1996-03-26 Gilead Sciences, Inc. Pyrimidine derivatives for labeled binding partners
US5567884A (en) 1994-03-09 1996-10-22 International Business Machines Corporation Circuit board assembly torsion tester and method
US5668127A (en) 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof
TW424090B (en) 1995-08-18 2001-03-01 Nat Science Council Pyrimidines as folate antimetabolites with selective activity against human brain cancer
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
US7282327B2 (en) 1996-01-23 2007-10-16 Affymetrix, Inc. Nucleic acid labeling compounds
GB9708611D0 (en) 1997-04-28 1997-06-18 Univ Cardiff Chemical compounds
US6110925A (en) 1997-08-07 2000-08-29 Research Corporation Technologies, Inc. Antibiotic for methicillin resistant bacteria
WO1999024452A2 (en) 1997-11-07 1999-05-20 Isis Pharmaceuticals, Inc. Pyrimidine derivatives for labeled binding partners
US6028183A (en) 1997-11-07 2000-02-22 Gilead Sciences, Inc. Pyrimidine derivatives and oligonucleotides containing same
DE19838998A1 (de) 1998-08-27 2000-03-09 Bayer Ag Neue Naturstoffderivate
SE9903894D0 (sv) 1999-10-28 1999-10-28 New Pharma Research Ab Novel compounds
EP1113008A1 (en) 1999-12-29 2001-07-04 Pfizer Products Inc. 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents
KR100358083B1 (ko) 2000-02-17 2002-10-25 에스케이케미칼주식회사 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도
BR0114837A (pt) 2000-10-18 2006-05-09 Pharmasset Ltd nucleosìdeos modificados para tratamento de infecções viróticas e proliferação celular anormal
DE10061541A1 (de) 2000-12-11 2002-06-20 Bayer Ag Arylamino-Dihydropyrimidinone
DE10061537A1 (de) 2000-12-11 2002-06-20 Bayer Ag beta-Alanin-Derivate
DE10061542A1 (de) 2000-12-11 2002-06-13 Bayer Ag Alkanoylamino-pyrimidine
DE10061538A1 (de) 2000-12-11 2002-06-20 Bayer Ag Ureido-Dihydropyrimidinone
WO2002048138A1 (en) 2000-12-14 2002-06-20 The Procter & Gamble Company Antimicrobial quinolones
US6900215B2 (en) 2000-12-15 2005-05-31 Merck Sharp & Dohme Ltd. Imidazo-pyrimidine derivatives as ligands for gaba receptors
AU2002230058B2 (en) 2001-01-29 2005-11-17 Bio-Rad Laboratories, Inc. Nucleic acid derivatives
TWI248936B (en) 2001-03-21 2006-02-11 Merck Sharp & Dohme Imidazo-pyrimidine derivatives as ligands for GABA receptors
US20030207804A1 (en) 2001-05-25 2003-11-06 Muthiah Manoharan Modified peptide nucleic acids
US20030158403A1 (en) 2001-07-03 2003-08-21 Isis Pharmaceuticals, Inc. Nuclease resistant chimeric oligonucleotides
CA2452458A1 (en) 2001-07-03 2003-01-16 Isis Pharmaceuticals, Inc. Nuclease resistant chimeric oligonucleotides
DE10133277A1 (de) 2001-07-09 2003-01-23 Bayer Ag ß-Alanin-Derivate
DE10141271A1 (de) 2001-08-23 2003-03-06 Bayer Ag Neue Tetrahydro-1,3,5-triazin-2-on-Derivate und ihre Verwendung
DE10208256A1 (de) 2002-02-26 2003-09-04 Bayer Ag Piperidinouracile
BR0308289A (pt) 2002-03-08 2005-01-11 Schering Plough Ltd Antibióticos do tipo florfenicol
AU2003225705A1 (en) 2003-03-07 2004-09-30 Ribapharm Inc. Cytidine analogs and methods of use
NZ545157A (en) 2003-08-12 2009-03-31 Achillion Pharmaceuticals Inc Isothiazoloquinolones and related compounds as anti-infective agents
EP1661897B1 (en) 2003-08-26 2013-12-04 Teijin Pharma Limited Pyrrolopyrimidinone derivative
TW200524880A (en) 2003-10-21 2005-08-01 Sankyo Co Pyrimidine compounds
WO2007014308A1 (en) 2005-07-27 2007-02-01 Achillion Pharmaceuticals, Inc. 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
CN101360720A (zh) 2005-11-15 2009-02-04 阿斯利康(瑞典)有限公司 新颖的2-氨基嘧啶酮衍生物及其用途
NZ544187A (en) 2005-12-15 2008-07-31 Ind Res Ltd Deazapurine analogs of 1'-aza-l-nucleosides
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
DE602007012161D1 (de) 2006-03-03 2011-03-10 Fujifilm Corp Härtbare Zusammensetzung, Tintenzusammensetzung, Tintenstrahlaufzeichnungsverfahren und Flachdruckplatte
JP2007270087A (ja) 2006-03-31 2007-10-18 Fujifilm Corp 硬化性組成物、インク組成物、インクジェット記録方法、印刷物、平版印刷版の製造方法、及び平版印刷版
KR20080003599A (ko) 2006-07-03 2008-01-08 에스케이케미칼주식회사 피롤로피리미디논 유도체의 겐티세이트 염 및 이의제조방법
MX2009000102A (es) 2006-07-03 2009-03-02 Sk Chemicals Co Ltd Sales de derivados de pirrolopirimidinona y proceso para prepararlas.
US20100112561A1 (en) 2006-08-25 2010-05-06 Stefan Lutz Fluorescent nucleoside analogues
PL2057165T3 (pl) 2006-09-07 2011-08-31 Victoria Link Ltd Acykliczne inhibitory aminowe fosforylaz i hydrolaz nukleozydowych
WO2008106224A1 (en) 2007-02-28 2008-09-04 Rib-X Pharmaceuticals, Inc. Macrolide compounds and methods of making and using the same
EP1964841A1 (en) 2007-02-28 2008-09-03 sanofi-aventis Imidazo[1,2-a]azine and their use as pharmaceuticals
EP2125816A2 (en) 2007-03-07 2009-12-02 Alantos Pharmaceuticals Holding, Inc. Metalloprotease inhibitors containing a heterocyclic moiety
JP2008222557A (ja) 2007-03-08 2008-09-25 Kotobuki Seiyaku Kk ピロロ［３，２−ｄ］ピリミジン誘導体及びこれを有効成分とする医薬組成物
US20080319200A1 (en) 2007-05-30 2008-12-25 Schering-Plough Animal Health Corp. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
CN101765585B (zh) 2007-06-12 2017-03-15 尔察祯有限公司 抗菌剂
GB0724342D0 (en) 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
KR20090098710A (ko) 2008-03-14 2009-09-17 주식회사 씨티아이바이오 세포투과성과 핵산 결합력이 좋은 펩타이드 핵산 유도체
UY32395A (es) 2009-01-27 2010-08-31 Takeda Pharmaceutical Compuesto con anillo fusionado y su uso
US20120263646A1 (en) 2009-10-15 2012-10-18 Guerbet Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
CN102725274A (zh) 2009-10-16 2012-10-10 Rib-X制药公司 抗微生物化合物和其制备和使用方法
CN104628729B (zh) 2009-10-16 2018-11-06 梅琳塔治疗公司 抗微生物化合物和其制备和使用方法
ES2675798T3 (es) 2009-10-16 2018-07-12 Melinta Therapeutics, Inc. Compuestos antimicrobianos y métodos para fabricar y usar los mismos
MX359743B (es) 2009-10-16 2018-10-08 Melinta Therapeutics Inc Compuestos antimicrobianos y métodos para fabricar y utilizar los mismos.
WO2012125832A2 (en) 2011-03-15 2012-09-20 Rib-X Pharmaceuticals, Inc. Antimicrobial agents
ES2665988T3 (es) * 2011-04-15 2018-04-30 Melinta Therapeutics, Inc. Compuestos antimicrobianos y métodos de fabricación y uso de los mismos
KR20160070066A (ko) 2013-09-09 2016-06-17 멜린타 테라퓨틱스, 인크. 항균 화합물, 및 이의 제조 방법 및 이용 방법
MX2016003046A (es) 2013-09-09 2016-09-08 Melinta Therapeutics Inc Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.

Also Published As

Publication number Publication date
EP3038623A1 (en) 2016-07-06
CA2923179A1 (en) 2015-03-12
JP2016529325A (ja) 2016-09-23
AU2014315045A1 (en) 2016-03-24
US20160220568A1 (en) 2016-08-04
WO2015035421A1 (en) 2015-03-12
EP3038623A4 (en) 2017-04-19
US9937183B2 (en) 2018-04-10

Similar Documents

Publication Publication Date Title
MX2016003046A (es) Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.
EP3409666A3 (en) Seca inhibitors and methods of making and using thereof
MX2015007556A (es) Derivados de manosa para tratar infecciones bacterianas.
GB2551642A (en) Methods and compositions relating to microbial treatment and diagnosis of dis-orders
AU2015205914B2 (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections
GB201013307D0 (en) Anti-microbial metal organic framework
BR112012018170B8 (pt) agente antimicrobiano para redução, inibição ou tratamento do crescimento microbiano, infecções microbianas, doenças inflamatórias, doenças ou condições virais resultantes de ou associadas aos mesmos
NZ733174A (en) Quinazoline derivatives used to treat hiv
MX2017010710A (es) Composición terapeútica y profiláctica producida por microbiota.
PH12015502401A1 (en) Compositions and methods for enhancing microbial stability
MX2017012545A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
MX2016009898A (es) Tratamientos para acne resistente.
EA201692303A1 (ru) Новая противоинфекционная стратегия против коинфекций, вызванных вирусом гриппа и s.aureus
MY179292A (en) Monobactam organic compounds for the treatment of bacterial infections
WO2019067380A3 (en) Treatment of mosaic viruses and bacterial infections of plants
IN2014MN02438A (es)
BR112013005426A2 (pt) "composto, composição, formulação farmacêutica, métodos para inibir uma enzima, para matar e/ou prevenir o crescimento de um micro-organismo, para tratar e/ou prevenir uma doença em um animal, e para inibir o domínio de edição de uma sintetase de t-rna, e, uso de um composto ou uma de combinação."
PH12017501019B1 (en) Isoxazole hydromaxamic acid compounds as lpxc inhibitors
EA201692494A1 (ru) Композиции, содержащие липохитоолигосахарид и микроорганизм для усиления роста растения
WO2016183532A8 (en) Bacteria engineered to treat a disease or disorder
WO2015175977A3 (en) Antisense antibacterial compounds and methods
MX2019005097A (es) Composiciones y metodos para tratar la enfermedad del enverdecimiento de los citricos.
PH12019500360A1 (en) Antibiotic compounds
WO2015100331A3 (en) Phenazine derivatives as antimicrobial agents
WO2016004513A8 (en) Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methods